Hutchison China MediTech Limited (LON:HCM) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $369.50. Hutchison China MediTech shares last traded at $355.00, with a volume of 23,131 shares.

Separately, HSBC started coverage on HUTCHISON CHINA/S in a research note on Wednesday, March 27th. They set a “buy” rating for the company.

The company has a debt-to-equity ratio of 8.26, a quick ratio of 3.10 and a current ratio of 3.45. The firm has a market capitalization of $2.37 billion and a PE ratio of -28.40. The stock has a 50 day moving average price of GBX 874.22.

About Hutchison China MediTech (LON:HCM)

Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments.

See Also: What are the economic characteristics of a bear market?

Receive News & Ratings for Hutchison China MediTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech and related companies with's FREE daily email newsletter.